Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2... by Valle, Juan W, Prof, Vogel, Arndt, Prof, Denlinger, Crystal S, MD, He, Aiwu Ruth, MD, Bai, Li-Yuan, Prof, Orlova, Rashida, Prof, Van Cutsem, Eric, Prof, Adeva, Jorge, MD, Chen, Li-Tzong, Prof, Obermannova, Radka, MD, Ettrich, Thomas J, MD, Chen, Jen-Shi, MD, Wasan, Harpreet, MD, Girvan, Allicia C, PhD, Zhang, Wei, PhD, Liu, Jiangang, MD, Tang, Chunlao, PhD, Ebert, Philip J, PhD, Aggarwal, Amit, PhD, McNeely, Samuel C, PhD, Moser, Brian A, MS, Oliveira, Joana M, PhD, Carlesi, Roberto, MD, Walgren, Richard A, MD, Oh, Do-Youn, Prof

Get full text